AIFA
-
News
Altroconsumo denounces Biogen. Dominant position for drug against SMA
Riportiamo il comunicato di Altroconsumo L’azienda farmaceutica Biogen è titolare dell’unica cura al momento disponibile in Italia contro l’atrofia muscolare…
Leggi » -
News
Horizon scanning. AIFA publishes the first report “Orizzonte Medicina. Scenario of incoming medicines”
AIFA – 19 giugno 2918 L’attività di Horizon Scanning ha una funzione strategica per l’AIFA poiché permette di identificare e…
Leggi » -
News
EMA. Campaign on social media to highlight the activity to make medicines safe and effective in Europe
EMA launches social media campaign to highlight how the European medicines regulatory network maintains the…
Leggi » -
News
AIFA. According to advances Giulia Grillo would have signed the decree appointing Saitta as president of AIFA
Aifa, si scioglie il nodo presidenza, arriva il via libera di Grillo ad Antonio Saitta RIFday – aprile 16, 2019…
Leggi » -
News
Li Bassi (Aifa): the sale of bulk medicines is being studied
Li Bassi (Aifa), aid for the environment and health from bulk medicines South Tyrol - 10 April 2019 Aid for…
Leggi » -
First floor
Price of medicines: a reply to the Director of AIFA. With the fetish of transparency, the hedging difficulties of a State with delusions of omnipotence are unloaded on the sector
The medicines market is heavily regulated. Even before some specific strategies to contain pharmaceutical expenditure, such as…
Leggi » -
News
Use of antibiotics, Aifa report: Italy still bringing up the rear compared to the European trend
L’uso di antibiotici in Italia, nonostante il trend in riduzione, è ancora superiore alla media europea. E se nel 2017…
Leggi » -
News
NAS: who they are and what they do. AIFA carabinieri unit
NAS, Carabinieri a tutela della nostra salute: chi sono e cosa fanno NAS (acronimo di: Nuclei Antisofisticazioni e Sanità dell’Arma),…
Leggi » -
News
Drug price. AIFA: Without transparency there can be no real competition.
Because Italy and Trump will vivisection drug prices. AIFA's word On medicines we are faced with an information asymmetry that…
Leggi » -
News
Brexit. Risk for shortages and professional mobility. For drugs registered in London, the authorization process should start almost from scratch.
Brexit, la filiera del farmaco è preoccupata. Rischio per carenze e mobilità professionale Federfarma – 15 febbraoio 2019 L’ipotesi di…
Leggi »